Subscribe Us

header ads

Recents

header ads

Stem Cells Market Size, Growth, Demands Outlook and Forecasts to 2027

Precedence Research - December 23, 2022

According to the research report, the global stem cells market size is expected to touch USD 17.79  Billion by 2027, from USD 9.3 Billion in 2020, growing with a significant CAGR of 8.61% from 2020 to 2027. 

Stem Cells Market Size 2020 to 2027

The stem cells market report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global stem cells market in conjunction with the geographical landscape of this vertical have also been included in this report.

The report offers intricate dynamics about different aspects of the global stem cells market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global stem cells market during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).

Sample Link @ https://www.precedenceresearch.com/sample/1118

 Scope of the Stem Cells Market Report

Report HighlightsDetails
Market SizeUSD 17.79 Billion by 2027
Growth RateCAGR of 8.61% From 2020-2027
Base Year2021
Historic Data2017 to 2020
Forecast Regiod2021 to 2027
Segments CoveredProduct, Application, Technology, Therapy
Regional ScopeNorth America, APAC, Europe, Latin America, MEAN, Rest of the World

This study covers a detailed segmentation of the global stem cells market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global stem cells market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.

Key Players

  • STEMCELL Technologies, Inc.
  • Osiris Therapeutics, Inc.
  • Cynata Therapeutics
  • Human Longevity, Inc.
  • Advanced Cell Technology, Inc.
  • BIOTIME, Inc.
  • Mesoblast Limited
  • Promethera Biosciences S.A. / N.V.
  • Merck Group
  • Takara Bio Group

Market Segmentation

 By Product

  • Adult Stem Cells
    • Neuronal Stem Cells
    • Mesenchymal Stem Cells
    • Dental Stem Cells
    • Umbilical Cord Stem Cells
    • Adipose-derived Stem Cells
    • HematopoieticStem Cells
    • Dedifferentiated fat (DFAT) Cells
    • Other ASC’s
  • Very Small Embryonic Like Stem Cells
  • Human Embryonic Stem Cells
  • Induced Pluripotent Stem Cells

By Application

  • Regenerative Medicine
    • Neurology
    • Oncology
    • Hematology
    • Injuries
    • Orthopedics
    • Incontinence
    • Diabetes
    • Liver Disorder
    • Others
  • Drug Discovery and development

By Technology

  • Cell Acquisition
    • Apheresis
    • Bone Marrow Harvest
    • Umbilical Blood Cord
  • Cryopreservation
  • Cell production
    • Therapeutic Cloning
    • Cell Culture
    • In-Vitro fertilization
    • Isolation
  • Expansion and Sub-Culture

By Therapy

  • Allogenic Stem Cell Therapy
  • Autologous Stem Cell Therapy

By Regional Outlook

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
  • Middle East & Africa
  • Latin America

Research Methodology

The research methodology adopted by analysts for compiling the global stem cells market report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.

During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.

For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global stem cells market.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Stem Cell Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Stem Cell Market

5.1. Covid-19: Stem Cell Industry Impact
5.2. Stem Cell Business Impact Assessment: Covid-19
5.2.1. Supply Chain Challenges/Disruption
5.2.2. Market Trends and Stem Cell Opportunities in the COVID-19 Landscape
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Stem Cell Manufacturers to deal with Covid-19 Pandemic Scenario

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition

Chapter 7. Global Stem Cell Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Stem Cell Market Revenue by Manufacturer (2015-2020)
7.1.1.2. Stem Cell Market Revenue Market Share by Manufacturer (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Capacity Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers

Chapter 8. Global Stem Cell Market, By Product Type

8.1. Stem Cell Market, by Product Type, 2016-2027
8.1.1. Adult Stem Cells
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Very Small Embryonic Like Stem Cells
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Human Embryonic Stem Cells
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Induced Pluripotent Stem Cells
8.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 9. Global Stem Cell Market, By Application

9.1. Stem Cell Market, by Application, 2016-2027
9.1.1. Regenerative Medicine
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Drug Discovery and development
9.1.2.1. Market Revenue and Forecast (2016-2027)

Chapter 10. Global Stem Cell Market, By Technology

10.1. Stem Cell Market, By Technology, 2016-2027
10.1.1. Cell Acquisition
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Cryopreservation
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Cell production
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Expansion and Sub-Culture
10.1.4.1. Market Revenue and Forecast (2016-2027)

Chapter 11. Global Stem Cell Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product (2016-2027)
11.1.2. Market Revenue Forecast by Application (2016-2027)
11.1.3. Market Revenue Forecast By Technology (2016-2027)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2016-2027)
11.1.4.2. Market Revenue Forecast (2016-2027)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2016-2027)
11.1.5.2. Market Revenue Forecast (2016-2027)
11.2. Europe
11.2.1. Market Revenue Forecast by Product (2016-2027)
11.2.2. Market Revenue Forecast by Application (2016-2027)
11.2.3. Market Revenue Forecast By Technology (2016-2027)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2016-2027)
11.2.4.2. Market Revenue Forecast (2016-2027)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2016-2027)
11.2.5.2. Market Revenue Forecast (2016-2027)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2016-2027)
11.2.6.2. Market Revenue Forecast (2016-2027)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2016-2027)
11.2.7.2. Market Revenue Forecast (2016-2027)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product (2016-2027)
11.3.2. Market Revenue Forecast by Application (2016-2027)
11.3.3. Market Revenue Forecast By Technology (2016-2027)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2016-2027)
11.3.4.2. Market Revenue Forecast (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2016-2027)
11.3.5.2. Market Revenue Forecast (2016-2027)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2016-2027)
11.3.6.2. Market Revenue Forecast (2016-2027)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2016-2027)
11.3.7.2. Market Revenue Forecast (2016-2027)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product (2016-2027)
11.4.2. Market Revenue Forecast by Application (2016-2027)
11.4.3. Market Revenue Forecast by Technology (2016-2027)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2016-2027)
11.4.4.2. Market Revenue Forecast (2016-2027)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2016-2027)
11.4.5.2. Market Revenue Forecast (2016-2027)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product (2016-2027)
11.5.2. Market Revenue Forecast by Application (2016-2027)
11.5.3. Market Revenue Forecast by Technology (2016-2027)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2016-2027)
11.5.4.2. Market Revenue Forecast (2016-2027)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2016-2027)
11.5.5.2. Market Revenue Forecast (2016-2027)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2016-2027)
11.5.6.2. Market Revenue Forecast (2016-2027)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2016-2027)
11.5.7.2. Market Revenue Forecast (2016-2027)

Chapter 12. Company Profiles

12.1. Company 1
12.1.1. Company Overview, Business Information, Manufacturing Area
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. STEMCELL Technologies, Inc.
12.2.1. Company Overview, Business Information, Manufacturing Area
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Osiris Therapeutics, Inc.
12.3.1. Company Overview, Business Information, Manufacturing Area
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. Cynata Therapeutics
12.4.1. Company Overview, Business Information, Manufacturing Area
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. Human Longevity, Inc.
12.5.1. Company Overview, Business Information, Manufacturing Area
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Advanced Cell Technology, Inc.
12.6.1. Company Overview, Business Information, Manufacturing Area
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. BIOTIME, Inc.
12.7.1. Company Overview, Business Information, Manufacturing Area
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Mesoblast Limited
12.8.1. Company Overview, Business Information, Manufacturing Area
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. Promethera Biosciences S.A. / N.V.
12.9.1. Company Overview, Business Information, Manufacturing Area
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Merck Group
12.10.1. Company Overview, Business Information, Manufacturing Area
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies
12.11. Takara Bio Group
12.11.1. Company Overview, Business Information, Manufacturing Area
12.11.2. Product Portfolio Analysis
12.11.2.1. Product Details, Specification, Application
12.11.3. Revenue and Gross Margin (2015-2020)
12.11.4. Recent Developments and Strategies
12.12. Company 12
12.12.1. Company Overview, Business Information, Manufacturing Area
12.12.2. Product Portfolio Analysis
12.12.2.1. Product Details, Specification, Application
12.12.3. Revenue and Gross Margin (2015-2020)
12.12.4. Recent Developments and Strategies

Chapter 13. Research Methodology

13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions

Chapter 14. Appendix

14.1. About Us
14.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com

 

Tags:

Post a Comment

0 Comments